Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News November 20th 2009

November 20th 2009

This edition of Glycosmedia is sponsored by Oxford University Press
A selection of books from Oxford University Press:

Diabetes

Diabetes Care – A Practical Manual

Oxford Handbook of Endocrinology and Diabetes

Oxford Handbook of Diabetes Nursing

Diabetes: The Biography

Sitagliptin approved as add-on to insulin
Sitagliptin (known as Januvia) has been approved by the European Commission as an add-on to insulin (with or without metformin) for people with Type 2 diabetes who cannot control their condition effectively with a combination of diet, physical activity and insulin (Diabetes UK)

Pioneering Scottish diabetes treatment centre opens
A laboratory which provides new cell-transplant treatment for people with Type 1 diabetes has been opened (Herald, Scotland, UK)

Estimated County-Level Prevalence of Diabetes and Obesity – United States, 2007
The results indicated distinct geographic patterns in diabetes and obesity prevalence in the United States (CDC, USA)

National Diabetes Fact Sheet
Use the fact sheet to learn about diabetes new cases, prevalence, deaths, and complications (CDC, USA)

On the road to reversing the impact of diabetes
2009 Annual Report (Canadian Diabetes Association)

A review of the efficacy of 10% dextrose as an alternative to high concentration glucose in the treatment of out-of-hospital hypoglycaemia
There is evidence to suggest that the titration of 10% dextrose to conscious state in severe hypoglycaemia is as efficacious as the administration of 50% dextrose, while reducing associated risks and producing better post-treatment outcomes (Journal of Emergency Primary Health Care)

Hemoglobin levels predicted proliferative diabetic retinopathy incidence
Higher hemoglobin levels appear to predict the incidence of proliferative diabetic retinopathy in patients with type 1 diabetes (Endocrine Today)

Alogliptin Use in Elderly People: A Pooled Analysis from Phase 2 and 3 Studies
Alogliptin was effective and well tolerated in the elderly patients enrolled in these studies (Journal of the American Geriatrics Society)

Quantity and quality of sleep and incidence of type 2 diabetes
From a a systematic review and meta-analysis: quantity and quality of sleep consistently and significantly predict the risk of the development of type 2 diabetes (Diabetes Care)

Intra-uterine Exposure to Maternal Diabetes
The intrauterine environment experienced by ODM increases diabetes and cardiovascular risk, over genetic factors; the effects strengthen during childhood (Diabetes Care)

Girl must spend every night of her life in hospital after developing unique diabetic condition
She treats each day as if it is her last due to her unique and unpredictable condition that has baffled doctors around the world (Daily Mail)

Doctors Say Low Pay for Diabetes Care Shortchanges Patients
Almost one-third of doctors in an industry-sponsored survey said they didn’t spend enough time with their diabetic patients and blamed low reimbursement rates for diabetes care, researchers said (Medpage Today)

Diabetes care and you
What diabetes care you can expect (Diabetes UK)

Categories: News Pre-2012

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Platinum Sponsors

Boehringer Ingelheim Lilly

Gold Sponsors

AstraZenecaNovo NordiskSanofi DiabetesNapp Diabetes

Silver Sponsors

Abbott Diabetes CareAbout Ascensia Diabetes CareWelsh Endocrinology and Diabetes Society (WEDS)Amgen

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2021 Glycosmedia Partnership